Skip to main content

Table 2 Biochemical variables obtained from microdialysis

From: A technique for continuous bedside monitoring of global cerebral energy state

Elapsed time (min)

LP ratio

Lactate (mM/L)

Pyruvate (μM/L)

Hemisphere

Sagittal sinus

Femoral

Hemisphere

Sagittal sinus

Femoral

Hemisphere

Sagittal sinus

Femoral

S −60

15 (14–18)

13 (9–16)

11 (11–19)

20.7 (10.7–30.0)

20.1 (10.7–20.3)

10.6 (10.1–1.9)

131 (107–178)

111 (106–123)

141 (99–160)

S −30

13 (11–16)

13 (6–16)

12 (10–17)

2.9 (2.4–3.5)

2.2 (2.2–2.2)

2 (1.7–2.6)

191 (151–205)

200 (193–371)

166 (161–175)

S

15 (11–18)

14 (8–26)

13 (10–21)

2.4 (2.1–3.1)

3.4 (2.6–5.2)

2.2 (1.6–3.4)

185 (153–210)

220 (161–388)

137 (131–153)

0

20 (17–41)

45 (32–46)

33 (30–36)

7.6 (7.2–8.0)

11.1 (10.5–11.7)

3 (2.3–4.0)

110 (107–149)

178 (144–208)

181 (129–193)

30

60 (27–117)

36 (23–63)

27 (26–27)

10.3 (7.8–11.0)

6.8 (4.6–12.1)

3.8 (3.7–4.4)

143 (92–163)

222 (147–230)

181 (111–187)

60

169 (45–418)

85 (36–112)

28 (26–35)

14.6 (11.8–17.2)

9 (6.6–13.2)

5.5 (5.2–6.8)

85 (43–137)

219 (128–272)

214 (144–286)

90

351 (105–774)

78 (42–117)

29 (25–33)

14.9 (10.2–18.8)

10.2 (7.0–13.6)

7.8 (4.2–9.3)

36 (21–49)

175 (111–208)

312 (256–348)

120

704 (97–1454)

94 (63–135)

29 (25–35)

12.9 (10.2–17.2)

9.7 (8.0–12.0)

9.7 (4.0–12.9)

28 (9–64)

129 (68–232)

305 (191–348)

150

879 (115–1238)

123 (36–332)

34 (24–37)

11.2 (10.6–15.9)

8.9 (8.0–13.8)

6.4 (3.0–10.9)

24 (9–210)

80 (29–269)

266 (162–308)

180

724 (264–2479)

150 (63–308)

30 (22–34)

12.9 (9.7–14.6)

8.8 (6.8–13.1)

7 (3.5–9.8)

38 (6–158)

90 (34–168)

215 157–274)

210

846 (243–1990)

309 (103–488)

27 (21–31)

13.4 (11.2–13.8)

9.6 (8.0–14.1)

4.4 (3.1–7.7)

8 (2–94)

81 (15–150)

192 (171–286)

Elapsed time (h)

Glucose (mM/L)

Glutamate (μM/L)

Glycerol (μM/L)

Hemisphere

Sagittal sinus

Femoral

Hemisphere

Sagittal sinus

Femoral

Hemisphere

Sagittal sinus

Femoral

S −01:00

2.4 (1.2–3.7)

3 (1.3–4.0)

5.2 (3.1–5.3)

5 (5–13)

130 (75–168)

183 (168–200)

27 (15–50)

31 (17–57)

34 (28–54)

S −00:30

2.9 (2.4–3.7)

2.9 (1.1–3.7)

4.1 (2.4–7.1)

8 (3–11)

162 (121–177)

199 (159–209)

26 (14–55)

28 (24–63)

34 (26–35)

S

3.6 (2.7–4.1)

1.7 (1.3–3.8)

3.7 (2.1–6.5

6 (4–7)

174 (104–204)

180 (148–209)

23 (13–41)

31 (23–55)

21 (20–29)

0

1.7 (1.5–1.9)

–

1.2 (0.7–1.6)

–

87 (50–121)

202 (169–221)

40 (40–40)

74 (49–100)

12 (11–14)

30

1.9 (1.2–2.4)

1.3 (0.6–4.2)

6.9 (1.3–9.2)

19 (4–55)

158 (84–159)

185 (163–206)

56 (32–108)

53 (37–112)

21 (8–32)

60

1.0 (0.7–1.4)

2 (0.02–2.2)

3.8 (1.1–8.2)

68 (36–101)

156 (132–204)

181 (158–204)

180 (133–201)

96 (53–159)

33 (14–117)

90

0.4 (0.3–0.5)

0.6 (0.02–1.5)

5.4 (1.7–7.6)

119 (119–119)

225 (204–248)

172 (149–195)

329 (254–337)

120 (102–190)

89 (29–486)

120

0.2 (1.0–0.3)

0.3 (0.04–0.7)

3.4 (1.2–7.3)

245 (199–291)

209 (209–209)

192 (152–198)

415 (318–455)

192 (123–258)

83 (23–671)

150

0.1 (0.1–1.0)

0.1 (0.02–0.5)

3.1 (0.5–5.6)

327 (231–329)

199 (152–259)

153 (107–177)

403 (377–548)

222 (151–286)

76 (19–621)

180

0.2 (0.1–1.3)

0.1 (0.02–0.2)

1.8 (0.5–5.9)

335 (289–367)

198 (133–256)

173 (139–180)

382 (333–547)

213 (191–230)

71 (18–314)

210

0.3 (0.1–0.9)

0.02 (0.02–0.7)

5.5 (0.9–8.1)

311 (232–322)

257 (227–287)

186 (184–188)

522 (474–612)

321 (268–331)

101 (26–182)

  1. Data are expressed as median (interquartile range). S indicates the start of bleeding to achieve a MAP of 40 mmHg
  2. LP lactate/pyruvate ratio